Fundraising Fox

Komathi Stem

Investor

Board of Directors at CoPeace Capital

Palo Alto, California, United States

About

Komathi Stem is a pharmaceutical and health IT executive with over 30 years of experience in drug development and healthcare technology. She has held leadership positions at companies including Eli Lilly, AstraZeneca, and Genentech, managing R&D and commercial functions with P&L responsibilities exceeding $50M across oncology, endocrine, cardio-metabolic, and other therapeutic domains. Stem co-founded Science 37 and monARC Bionetworks, which together raised over $150M in funding, and currently serves as Strategic Advisor at Oncoustics.

Experience

  1. OncousticsStrategic Advisorcurrent2021 — presentSan Francisco Bay Area
  2. ReThynk ConsultingChief Executive Officercurrent2016 — presentPalo Alto, California, United States
  3. CoPeaceBoard Membercurrent2018 — presentDenver, Colorado, United States
  4. GlookoChief Operating Officer2020 — 2024Palo Alto, CA
  5. monARC Bionetworks, Inc.Founder and CEO2016 — 2019Palo Alto, CA
  6. GenentechStrategic Innovation Consultant2016 — 2017
  7. GenentechSr. Director, Product Development2006 — 2016South San Francisco
  8. Science 37, Inc.Chief Operating Officer and Strategic Advisor2014 — 2016Los Angeles Metropolitan Area
  9. AstraZenecaSr. Director2003 — 2006
  10. Eli Lilly and CompanyVariety of Positions1992 — 2003Indianapolis

Skills & more

Patient RecruitmentHuman Resources (HR)Strategic LeadershipResearch and Development (R&D)Strategic PartnershipsLeadershipBoard of DirectorsPatient AdvocacyBiopharmaceuticalsBusiness StrategyKey MetricsFinancial Modeling
+12 moreFinancePatient EngagementDigital StrategyAI/ML SolutionsCorporate StrategyCreativity and InnovationDecentralized clinical trialsRemote Patient MonitoringCTMSClinical Trial Management System (CTMS)Product DevelopmentRegulatory Affairs

Languages Tamil

From Komathi's professional profile.

Colleagues at CoPeace Capital

Andy Eckert
COO at CoPeace Capital
Barbara Winter
Impact Director at CoPeace Capital
Betsy Poell
Advisory Council at CoPeace Capital
Brad Tompkins
Board of Directors at CoPeace Capital
Craig Jonas
CEO and Founder at CoPeace Capital
Craig Jonas, Ph.D.
Founder & CEO at CoPeace Capital
Dan Hattori
Strategic Financial Advisor at CoPeace Capital
Derek Scott
Vice President of Marketing at CoPeace Capital

Frequently asked questions

Who is Komathi Stem?
Komathi Stem is a pharmaceutical and health IT executive with over 30 years of experience in drug development and healthcare technology. She has held leadership positions at companies including Eli Lilly, AstraZeneca, and Genentech, managing R&D and commercial functions with P&L responsibilities exceeding $50M across oncology, endocrine, cardio-metabolic, and other therapeutic domains. Stem co-founded Science 37 and monARC Bionetworks, which together raised over $150M in funding, and currently serves as Strategic Advisor at Oncoustics.
Where does Komathi Stem work?
Komathi Stem is Board of Directors at CoPeace Capital.
Where did Komathi Stem go to school?
Komathi Stem studied at University of Virginia (Master's degree, Biomedical/Medical Engineering); University of Virginia (MA, Biomedical Engineering); St. Olaf College (Bachelor of Science (BS), Mathematics).

Same school

Also attended University of Virginia409

Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures

+ 403 more

Also attended St. Olaf College9

Galen MasonManaging Director at Service Provider CapitalJeff CaputoExecutives in Residence at GENERAL INCEPTIONMargo HaysSenior Advisor at TSG Consumer PartnersTyler HayesPrincipal at Thuja CapitalStuart MasonAdvisor at Transpose Platform ManagementAllison BoxerManaging Director & Academic Lecturer at Sorenson Impact

+ 3 more

Shared employers

Also worked at Oncoustics2

James WangGeneral Partner at Creative VenturesEmmanuel HuiInvestor at Saltagen Ventures

Also worked at Glooko4

Pablo BariolaInvestor at Inception Studio CapitalAlicia GarabedianVice President at Left Lane CapitalRuss JohannessonChief Executive Officer, Caregentic at Aegis VenturesWill VaughnOperating Advisor, UX at Workshop Venture Partners

Also worked at Genentech101

David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures

+ 95 more

Also worked at Science 37, Inc.1

Cris De LucaPartner, Digital at Sanofi Ventures